Figure (Fluticasone Fig1)
Fluticare Spray, Metered
Product Images NDC 57483-180
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Fluticare (NDC 57483-180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Innovus Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Fluticasone Fig10)
An illustration showing a stylized image of a human nose centered between two '1x' symbols. The image likely indicates nasal usage or dosage frequency for a nasal spray product.*
Figure (Fluticasone Fig11)
An illustration showing a stylized orange nose flanked by the text '2x' on both left and right sides, likely indicating usage instructions or dosage frequency related to nasal spray application.*
Figure (Fluticasone Fig12)
An instructional diagram showing a nasal spray device with spray droplets directed outward, and an eye symbol with a red cross over it, indicating that the nasal spray should not be sprayed into the eyes.*
Figure (Fluticasone Fig13)
Figure (Fluticasone Fig14)
An instructional diagram showing the first step for using a nasal spray. The diagram includes an image of the spray nozzle cap above the nasal spray bottle with a double-headed arrow between them, indicating removal or attachment of the cap.*
Figure (Fluticasone Fig15)
An instructional illustration labeled with the number 2, showing a blue nasal spray nozzle spraying downward toward a small, gray cap or cover positioned below it, indicating a step in usage or assembly of a nasal spray device.*
Figure (Fluticasone Fig16)
An instructional illustration showing a blue nasal spray bottle with an arrow pointing downwards above it and upwards below it, indicating a step likely related to administering or preparing the nasal spray. A number '3' in light blue is positioned to the left of the arrows and bottle.*
Figure (Fluticasone Fig17)
Illustration of a nasal spray bottle inside a glass of water, depicting hydration or rinsing related to nasal spray use.*
Figure (Fluticasone Fig18)
Figure (Fluticasone Fig19)
An instructional illustration showing a hand holding a FLUTICARE nasal spray bottle, labeled with fluticasone propionate 50 ug. The arrows and lines around the bottle indicate shaking or motion to prepare the spray for use.*
Figure (Fluticasone Fig2)
FLUTICARE 50 micrograms per spray, metered nasal spray packaging by Innovus Pharmaceuticals, Inc. The label features the proprietary and generic name (fluticasone propionate), product form, and dosage strength. The packaging is primarily white with text and branding elements.*
Figure (Fluticasone Fig20)
An instructional illustration showing hands removing the cap from a nasal spray bottle labeled FLUTICARE, fluticasone propionate. The image demonstrates the correct way to hold and prepare the metered nasal spray for use.*
Figure (Fluticasone Fig21)
An instructional illustration showing a person using a metered nasal spray. The person holds the spray bottle near the nostril, with an arrow indicating the spray direction into the nasal passage.*
Figure (Fluticasone Fig22)
An instructional illustration showing a person using a nasal spray. The person is holding the spray device and positioning it near one nostril, presumably for nasal administration of the spray.*
Figure (Fluticasone Fig23)
An instructional illustration showing a person using a metered nasal spray. The person holds the spray bottle at the base with one hand and inserts the nozzle into one nostril. The other hand is positioned to close the opposite nostril by pressing it gently. Arrows indicate the direction of movement and spray actuation.*
Figure (Fluticasone Fig24)
An illustration of a nasal spray bottle with the tip indicated by a green circle and labeled as 'Tip.' The diagram focuses on identifying the tip component of the metered nasal spray device.*
Figure (Fluticasone Fig25)
An illustration showing a nasal spray bottle aimed at a side view outline of a human nose. A dashed green line indicates the spray aiming direction from the bottle into the nostril.*
Figure (Fluticasone Fig26)
An instructional illustration showing a person using a nasal spray. The person holds the spray bottle near their nose with one hand and appears to be about to insert the nozzle into a nostril, indicated by directional arrows.*
Package Label.principal Display Panel (50 mcg per spray (60 Metered Sprays, Bottle Label))
FLUTICARE 50 mcg per spray nasal spray label. The label identifies fluticasone propionate as the active ingredient in a 0.54 FL OZ (15.8 mL) spray with 120 metered sprays per container. It is an allergy symptom reliever distributed by Innovus Pharmaceuticals, Inc. The label includes usage instructions, storage recommendations, and manufacturing origin (Made in India).*
Figure (Fluticasone Fig28)
The flap-style carton label for FLUTICARE Fluticasone Propionate Nasal Spray, USP contains detailed Drug Facts, instructions, warnings, and inactive ingredient lists. The front panel highlights the product as a 50 mcg per spray metered nasal spray, labeled as an allergy symptom reliever with 120 sprays total (0.54 FL OZ). Manufacturer information shows Innovus Pharmaceuticals, Inc. with a barcode and a tamper-evident notice. The label includes usage directions, precautions for children, and symptom relief information.*
Figure (Fluticasone Fig3)
An illustration showing allergens interacting with a triggered cell, which releases inflammatory substances. This diagram visually represents the biological process involved in nasal inflammation responses.*
Figure (Fluticasone Fig4)
An illustration showing a nasal spray device producing a spray mist, indicating its use as a metered nasal spray delivery system.*
Figure (Fluticasone Fig5)
An illustration depicting common allergy symptoms and triggers. It categorizes nasal symptoms such as congestion, runny nose, sneezing, and itchy nose, alongside eye symptoms including itchy and watery eyes. Triggers are divided into outdoor allergens like weed, grass, and tree pollen; animal allergens such as cats and dogs; and indoor allergens including dust, dust mites, and mold.*
Figure (Fluticasone Fig6)
Figure (Fluticasone Fig7)
An instructional illustration showing a green nasal spray bottle pointing towards an eye with a red prohibition symbol overlay, indicating that the nasal spray should not be sprayed into the eye.*
Figure 8 (Fluticasone Fig8)
Figure (Fluticasone Fig9)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
